GSK Says Patent Deal Relevant To Abbott HIV Drug Suit
GlaxoSmithKline told a North Carolina federal judge Wednesday that it should be allowed to argue in its lawsuit accusing Abbott Laboratories of violating a license agreement by raising the price of...To view the full article, register now.
Already a subscriber? Click here to view full article